Johnson & Johnson Strikes Drug Pricing Deal With Trump Administration in Exchange for Tariff Relief
Pharmaceutical giant Johnson & Johnson announces participation in Trump's TrumpRx.gov discount drug platform in exchange for tariff exemptions, marking a new era of corporate-government dealmaking on drug prices.